Cargando…
The trimer to monomer transition of Tumor Necrosis Factor-Alpha is a dynamic process that is significantly altered by therapeutic antibodies
The cytokine tumor necrosis factor-alpha (TNF-α) readily forms homotrimers at sub-nM concentrations to promote inflammation. For the treatment of inflammatory diseases with upregulated levels of TNF-α, a number of therapeutic antibodies are currently used as scavengers to reduce the active TNF-α con...
Autores principales: | Daub, Herwin, Traxler, Lukas, Ismajli, Fjolla, Groitl, Bastian, Itzen, Aymelt, Rant, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283243/ https://www.ncbi.nlm.nih.gov/pubmed/32518229 http://dx.doi.org/10.1038/s41598-020-66123-5 |
Ejemplares similares
-
Validation of the Slow Off‐Kinetics of Sirtuin‐Rearranging Ligands (SirReals) by Means of Label‐Free Electrically Switchable Nanolever Technology
por: Schiedel, Matthias, et al.
Publicado: (2020) -
Polymerase/DNA interactions and enzymatic activity: multi-parameter analysis with electro-switchable biosurfaces
por: Langer, Andreas, et al.
Publicado: (2015) -
A monomer-trimer model supports intermittent glucagon fibril growth
por: Košmrlj, Andrej, et al.
Publicado: (2015) -
Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
por: van Schie, Karin A., et al.
Publicado: (2016) -
Spectral Signatures of Protonated Noble Gas Clusters of Ne, Ar, Kr, and Xe: From Monomers to Trimers
por: Tan, Jake A., et al.
Publicado: (2022)